• A
  • A
  • A
日本語 Help
Science and technology information site for articles, patents, researchers information, etc.

Co-authoring Researcher

Co-inventing Researcher

Researcher similar to the Researcher

Article similar to the Researcher

Patent similar to the Researcher

Research Project similar to the Researcher

Article(J-GLOBAL estimation)

Patent(J-GLOBAL estimation)

Rchr
J-GLOBAL ID:202001010788910390   Update date: Feb. 01, 2024

Panthee Suresh

パンシー スレス | Panthee Suresh
Clips
Affiliation and department:
Research field  (3): Infectious disease ,  Genomics ,  Applied microbiology
Research keywords  (6): Third generation sequencing ,  secondary metabolite genomics ,  chemical biology ,  menaquinone ,  microbial genetics ,  antibiotics
Research theme for competitive and other funds  (4):
  • 2022 - 2025 An efficient approach to find therapeutically effective antifungal agents
  • 2019 - 2021 Biochemical analysis of long chain menaquinone biosynthesis and elucidation of HepT as an antimicrobial target
  • 2017 - 2020 Comprehensive analysis of pathogenic ncRNA in host environment
  • 2012 - 2015 New era of chemical library development using biomediator
Papers (54):
  • Junhao Fu, Yosuke Nakata, Hiroaki Itoh, Suresh Panthee, Hiroshi Hamamoto, Kazuhisa Sekimizu, Masayuki Inoue. Molecular Editing Enhances Oxidation Resistance of Mena-quinone-Targeting Antibiotics Lysocin E and WAP-8294A2. Chemistry - A European Journal. 2023
  • Yosuke Nakata, Junhao Fu, Hiroaki Itoh, Suresh Panthee, Hiroshi Hamamoto, Kazuhisa Sekimizu, Masayuki Inoue. Construction of Five Tryptophan Isomers and Application of the Isomers to Solid-Phase Total Syntheses of Lysocin E Derivatives. Chemistry (Weinheim an der Bergstrasse, Germany). 2023. e202301225
  • Geberemichal Geberetsadik, Akane Inaizumi, Akihito Nishiyama, Takehiro Yamaguchi, Hiroshi Hamamoto, Suresh Panthee, Aki Tamaru, Manabu Hayatsu, Yusuke Mizutani, Shaban Amina Kaboso, et al. Lysocin E Targeting Menaquinone in the Membrane of Mycobacterium tuberculosis Is a Promising Lead Compound for Antituberculosis Drugs. Antimicrobial agents and chemotherapy. 2022. 66. 9. e0017122
  • Hiroshi Hamamoto, Suresh Panthee, Atmika Paudel, Suguru Ohgi, Yutaka Suzuki, Koichi Makimura, Kazuhisa Sekimizu. Transcriptome change of Staphylococcus aureus in infected mouse liver. Communications biology. 2022. 5. 1. 721-721
  • 浜本 洋, Panthee Suresh, Paudel Atmika, 宮下 惇嗣, 関水 和久. 選抜ワークショップ5:抗菌性物質、薬剤耐性 新規抗生物質ライソシンEは宿主と微生物の相互作用を利用して高い治療効果を発揮する. 日本細菌学雑誌. 2022. 77. 1. 57-57
more...
MISC (2):
  • 浜本洋, 石島早苗, PANTHEE Suresh, 関水和久. Cryptococcus neoformansの病原性因子の網羅的探索. 関東医真菌懇話会プログラム・抄録集. 2022. 41st
  • 浜本洋, PANTHEE Suresh, PAUDEL Atmika, 宮下惇嗣, 関水和久, 関水和久. A novel antibiotic Lysocin E exhibits high therapeutic efficacy through host-microbe interaction. 日本細菌学雑誌(Web). 2022. 77. 1
Education (3):
  • 2008 - 2011 Tokyo Medical and Dental University Graduate School of Biomedical Science Biomedical Science PhD Program
  • 2006 - 2008 Kathmandu University School of Science Masters of Pharmacy in Pharmaceutical Care
  • 2001 - 2005 Tribhuvan University Institute of Medicine Bachelor of Pharmacy
Work history (6):
  • 2017/08 - 現在 Sustainable Study and Research Institute
  • 2016/04 - 現在 Teikyo University Institute of Medical Mycology
  • 2015/09 - 2016/03 The University of Tokyo Graduate School of Pharmaceutical Sciences
  • 2011/10 - 2015/08 RIKEN RIKEN Center for Sustainable Resource Science
  • 2006/01 - 2008/09 Nobel College, Pokhara University
Show all
Awards (2):
  • 2019/12 - Teikyo University Institute of Medical Mycology Hiratani Award Genome sequencing and analysis of Candida albicans TIMM 1768
  • 2012/09 - Government of Nepal Nepal Bidhya Bhusan category "A" Unveiling the regulatory network of secondary metabolism from Streptomyces reveromyceticus SN-593
Association Membership(s) (3):
American Society of Microbiology (ASM) ,  Nepal Pharmaceutical Association (NPA) ,  Graduate Pharmacists' Association, Nepal (GPAN)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page